| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neurogene Inc. | President and CFO | Common Stock | 109,843 | $2,758,113 | $25.11 | 27 Feb 2026 | Direct |
| Neurogene Inc. | President and CFO | Stock Option (Right to Buy) | 131,900 | 20 Feb 2026 | Direct | ||
| Neurogene Inc. | President and CFO | Employee Stock Option (Right to buy) | 122,000 | 26 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NGNE | Neurogene Inc. | 27 Feb 2026 | 1 | -$120,526 | 4 | President and CFO | 03 Mar 2026, 17:03 |
| NGNE | Neurogene Inc. | 20 Feb 2026 | 2 | $0 | 4 | President and CFO | 24 Feb 2026, 18:49 |
| NGNE | Neurogene Inc. | 26 Mar 2025 | 2 | $0 | 4 | President and CFO | 28 Mar 2025, 21:29 |
| NGNE | Neurogene Inc. | 13 Mar 2025 | 1 | -$76,247 | 4 | President and CFO | 17 Mar 2025, 17:14 |
| NGNE | Neurogene Inc. | 22 Nov 2024 | 1 | +$491,400 | 4 | President and CFO | 25 Nov 2024, 21:29 |
| NGNE | Neurogene Inc. | 13 Mar 2024 | 2 | $0 | 4 | President and CFO | 14 Mar 2024, 20:53 |
| NGNE | Neurogene Inc. | 18 Dec 2023 | 0 | $0 | 3 | President and CFO | 26 Dec 2023, 18:16 |